Zogenix Inc. buy melinda
Start price
22.06.17
/
50%
€13.44
Target price
29.09.17
€30.00
Performance (%)
79.10%
End price
29.09.17
€24.07
Summary
This prediction ended on 29.09.17 with a price of €24.07. With a performance of 79.10% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % | 49,94 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % | 77,36 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % | 51,28 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % | 59,46 % |
Comments by melinda for this prediction
In the thread Zogenix Inc. diskutieren
* Zogenix Inc. - 22. Juni erteilte die US FDA seine experimentelle Droge, die Ausweisung von Orphan - ZX008 Medikament für die Behandlung von Lennox-Gastaut - Syndrom
(Vom Mitglied beendet)